The Immunohistochemistry Shared Resource (ISR) is new to the CCSG, but its services have been available for nearly a decade under the auspices of another VUMC research center. Many cancer investigators use this Resource, which offers immunohistochemical staining in mouse tissue and/or cellular sections. It is well recognized that the ability to make use of the large number of antibodies that have become available in Irecent years requires development of standardized immunoprotocols. The ISR centralizes this task and prevents needless repetition, and gives access to nationally-certified personnel and state-of-the-art equipment. In brief, the ISR supports cancer-related research by maintaining stocks of relevant markers (antisera) with ready-to-go protocols; screening/optimizing antisera for immunohistochemistry; standardizing quality assurance; and providing immunostaining of tissue microarrays. It will support state-of-the-art embedding, sectioning, and staining for microscopic specimens by providing paraffin embedding; frozen embedding and sectioning; sections suitable for routine staining, immunostaining, in situ hybridization, laser capture dissention and for RNA extraction from archival blocks; and the provision of guidance in techniques of quantitative morphometric analysis. Dr. Lillian B. Nanney is the Director of the Immunohistochemistry Shared Resource. She brings to this venture over 20 years of research and teaching experience in microscopy, histology and cell biology. She is supported by a lab manager and other technicians who are readily available to VICC investigators.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA068485-10
Application #
7116945
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2005-09-01
Budget End
2006-08-31
Support Year
10
Fiscal Year
2005
Total Cost
$54,500
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Maacha, Selma; Hong, Jun; von Lersner, Ariana et al. (2018) AXL Mediates Esophageal Adenocarcinoma Cell Invasion through Regulation of Extracellular Acidification and Lysosome Trafficking. Neoplasia 20:1008-1022
Schulte, Michael L; Fu, Allie; Zhao, Ping et al. (2018) Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models. Nat Med 24:194-202
Petersen, Christine P; Meyer, Anne R; De Salvo, Carlo et al. (2018) A signalling cascade of IL-33 to IL-13 regulates metaplasia in the mouse stomach. Gut 67:805-817
Wang, Jing; Zhao, Yue; Zhou, Xiaofan et al. (2018) Nascent RNA sequencing analysis provides insights into enhancer-mediated gene regulation. BMC Genomics 19:633
Galligan, James J; Wepy, James A; Streeter, Matthew D et al. (2018) Methylglyoxal-derived posttranslational arginine modifications are abundant histone marks. Proc Natl Acad Sci U S A 115:9228-9233
Davenport, James R; Su, Timothy; Zhao, Zhiguo et al. (2018) Modifiable lifestyle factors associated with risk of sessile serrated polyps, conventional adenomas and hyperplastic polyps. Gut 67:456-465
Pannala, Venkat R; Wall, Martha L; Estes, Shanea K et al. (2018) Metabolic network-based predictions of toxicant-induced metabolite changes in the laboratory rat. Sci Rep 8:11678
Zhao, Shilin; Li, Chung-I; Guo, Yan et al. (2018) RnaSeqSampleSize: real data based sample size estimation for RNA sequencing. BMC Bioinformatics 19:191
Croessmann, Sarah; Sheehan, Jonathan H; Lee, Kyung-Min et al. (2018) PIK3CA C2 Domain Deletions Hyperactivate Phosphoinositide 3-kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive to PI3K? Inhibitors. Clin Cancer Res 24:1426-1435
Doxie, Deon B; Greenplate, Allison R; Gandelman, Jocelyn S et al. (2018) BRAF and MEK inhibitor therapy eliminates Nestin-expressing melanoma cells in human tumors. Pigment Cell Melanoma Res 31:708-719

Showing the most recent 10 out of 2462 publications